US5019556A
(en)
*
|
1987-04-14 |
1991-05-28 |
President And Fellows Of Harvard College |
Inhibitors of angiogenin
|
US5866701A
(en)
*
|
1988-09-20 |
1999-02-02 |
The Board Of Regents For Northern Illinois University Of Dekalb |
HIV targeted hairpin ribozymes
|
CA1340323C
(en)
*
|
1988-09-20 |
1999-01-19 |
Arnold E. Hampel |
Rna catalyst for cleaving specific rna sequences
|
US5624824A
(en)
*
|
1989-03-24 |
1997-04-29 |
Yale University |
Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
|
US5168053A
(en)
*
|
1989-03-24 |
1992-12-01 |
Yale University |
Cleavage of targeted RNA by RNAase P
|
DE4091533T
(da)
*
|
1989-08-31 |
1992-01-30 |
|
|
US5225337A
(en)
*
|
1989-09-25 |
1993-07-06 |
Innovir Laboratories, Inc. |
Ribozyme compositions and methods for use
|
US5225347A
(en)
*
|
1989-09-25 |
1993-07-06 |
Innovir Laboratories, Inc. |
Therapeutic ribozyme compositions and expression vectors
|
DE3933384A1
(de)
*
|
1989-10-06 |
1991-04-18 |
Hoechst Ag |
Multifunktionelle rna mit selbstprozessierungsaktivitaet, ihre herstellung und ihre verwendung
|
DE3935473A1
(de)
*
|
1989-10-25 |
1991-05-02 |
Hoechst Ag |
Rna mit endonuclease- und antisense-aktivitaet, ihre herstellung und ihre verwendung
|
BR9105935A
(pt)
*
|
1990-01-11 |
1992-11-17 |
Isis Pharmaceuticals Inc |
Composicao,analogo de oligonucleotideo,oligonucleotideo sequenciado misto,processo para a preparacao de nucleosideos 2'-substituidos,composicao para modular a atividade de rna,processos para modular a producao de uma proteina por um organismo,para tratar um animal,para detectar a presenca ou ausencia de rna,oligonucleotideo ou analogo de analogo de oligonucleotideo resistente a nuclease e processo para tratar um organismo tendo uma doenca
|
DE4002885A1
(de)
*
|
1990-02-01 |
1991-08-08 |
Hoechst Ag |
Expression einer multigen rna mit self-splicing aktivitaet
|
US5519164A
(en)
*
|
1990-02-01 |
1996-05-21 |
Hoechst Aktiengesellschaft |
Expression of a multigene RNA having self-splicing activity
|
US5180818A
(en)
*
|
1990-03-21 |
1993-01-19 |
The University Of Colorado Foundation, Inc. |
Site specific cleavage of single-stranded dna
|
WO1991018625A1
(en)
*
|
1990-06-07 |
1991-12-12 |
City Of Hope |
Ribozyme mediated reversal of transformation by cleavage of the hras oncogene rna
|
WO1991018913A1
(en)
*
|
1990-06-07 |
1991-12-12 |
City Of Hope |
Ribozyme mediated reversal of transformation by cleavage of the hras oncogene rna
|
CA2084790C
(en)
*
|
1990-06-19 |
2002-04-09 |
Philip Anthony Jennings |
Endonucleases
|
US6008343A
(en)
*
|
1990-06-19 |
1999-12-28 |
Gene Shears Pty. Ltd. |
Nucleotide based endonucleases
|
EP0639226A1
(en)
*
|
1990-06-26 |
1995-02-22 |
The Wistar Institute |
Rna molecule for use in treating leukemias
|
US5246921A
(en)
*
|
1990-06-26 |
1993-09-21 |
The Wistar Institute Of Anatomy And Biology |
Method for treating leukemias
|
EP0558490A1
(en)
*
|
1990-07-26 |
1993-09-08 |
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS (FO.R.T.H.) INSTITUTE OF MOLECULAR BIOLOGY & BIOTECHNOLOGY |
Portable ribozyme cassettes, dna sequences containing them, ribozymes encoded by these dna sequences, and compositions containing these ribozymes
|
CA2093664C
(en)
|
1990-10-12 |
2003-07-29 |
Fritz Eckstein |
Modified ribozymes
|
NZ241311A
(en)
*
|
1991-01-17 |
1995-03-28 |
Gen Hospital Corp |
Rna sequence having trans-splicing activity, plant strains
|
NZ314629A
(en)
*
|
1991-01-17 |
2000-08-25 |
Gen Hospital Corp |
Use trans-splicing ribozymes to prepare medicaments for gene therapies
|
FR2675803B1
(fr)
*
|
1991-04-25 |
1996-09-06 |
Genset Sa |
Oligonucleotides fermes, antisens et sens et leurs applications.
|
FI913197A0
(fi)
|
1991-07-01 |
1991-07-01 |
Xyrofin Oy |
Nya jaeststammar med reducerad foermaoga att metabolisera xylitol, foerfarande foer bildande av dessa och deras anvaendning vid framstaellning av xylitol.
|
EP0623171A4
(en)
*
|
1992-01-13 |
1997-02-12 |
Univ Duke |
ENZYMATIC RNA MOLECULES.
|
DK0592685T3
(da)
*
|
1992-04-17 |
2002-02-11 |
Kirin Brewery |
Plante, som er resistent over for to eller flere vira, og fremstilling deraf
|
RU94046396A
(ru)
*
|
1992-06-29 |
1996-11-10 |
Джин Ширс Пти.Лтд. (AU) |
Нуклеиновая кислота, днк, вектор, способ получения растения или животного, способ получения клеток, способ создания животного, животное, трансгенное животное, трансгенное растение, плоды, черенки и семена, растительные клетки, способ вмешательства в репликацию вируса
|
ATE236975T1
(de)
*
|
1992-07-02 |
2003-04-15 |
Sankyo Co |
Haarnadelförmiges ribozym
|
US5409823A
(en)
*
|
1992-09-24 |
1995-04-25 |
Ciba-Geigy Corporation |
Methods for the production of hybrid seed
|
CA2148368A1
(en)
*
|
1992-11-03 |
1994-05-11 |
Mouldy Sioud |
Tnf-.alpha. ribozymes and degradation resistant mrna derivatives linked to tnf-.alpha. ribozymes
|
US5864028A
(en)
*
|
1992-11-03 |
1999-01-26 |
Gene Shears Pty. Limited |
Degradation resistant mRNA derivatives linked to TNF-α ribozymes
|
EP0681613B1
(en)
*
|
1992-12-04 |
2002-05-08 |
Yale University |
Ribozyme amplified diagnostics
|
EP0707638A4
(en)
*
|
1992-12-04 |
1998-05-20 |
Innovir Lab Inc |
REGULABLE NUCLEIC ACID FOR THERAPEUTIC USE AND METHODS OF USE THEREOF
|
US6080851A
(en)
*
|
1992-12-04 |
2000-06-27 |
American Home Products Corporation |
Ribozymes with linked anchor sequences
|
FR2701960B1
(fr)
*
|
1993-02-26 |
2002-09-13 |
Gene Shears Pty Ltd |
Polyribozyme apte à conférer, aux plantes, une résistance aux virus et plantes résistantes produisant ce polyribozyme.
|
US5817635A
(en)
*
|
1993-08-09 |
1998-10-06 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Modified ribozymes
|
AU5334294A
(en)
*
|
1993-10-15 |
1995-05-04 |
Dkfz Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts |
Asymmetric hammerhead ribozymes and nucleotide sequences for their construction
|
US5869248A
(en)
*
|
1994-03-07 |
1999-02-09 |
Yale University |
Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences
|
US5998193A
(en)
*
|
1994-06-24 |
1999-12-07 |
Gene Shears Pty., Ltd. |
Ribozymes with optimized hybridizing arms, stems, and loops, tRNA embedded ribozymes and compositions thereof
|
US6350934B1
(en)
|
1994-09-02 |
2002-02-26 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid encoding delta-9 desaturase
|
US5683873A
(en)
*
|
1995-01-13 |
1997-11-04 |
Innovir Laboratories, Inc. |
EGS-mediated inactivation of target RNA
|
US6057153A
(en)
*
|
1995-01-13 |
2000-05-02 |
Yale University |
Stabilized external guide sequences
|
FR2730637B1
(fr)
|
1995-02-17 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
|
US6004806A
(en)
*
|
1995-06-07 |
1999-12-21 |
Commonwealth Scientific And Industrial Research Organization |
Optimized minizymes and miniribozymes and uses thereof
|
AU708995B2
(en)
*
|
1995-06-07 |
1999-08-19 |
Gene Shears Pty. Limited |
Optimized minizymes and miniribozymes and uses thereof
|
US6010904A
(en)
*
|
1995-06-07 |
2000-01-04 |
The General Hospital Corporation |
Cell ablation using trans-splicing ribozymes
|
AU6761796A
(en)
*
|
1995-07-13 |
1997-04-01 |
Dowelanco |
Compositions and method for modulation of gene expression in plants
|
US5824519A
(en)
*
|
1995-11-08 |
1998-10-20 |
Medical University Of South Carolina |
Tissue-specific and target RNA-specific ribozymes
|
US5877162A
(en)
*
|
1996-03-14 |
1999-03-02 |
Innovir Laboratories, Inc. |
Short external guide sequences
|
US6620805B1
(en)
|
1996-03-14 |
2003-09-16 |
Yale University |
Delivery of nucleic acids by porphyrins
|
US6610478B1
(en)
|
1996-08-16 |
2003-08-26 |
Yale University |
Phenotypic conversion of cells mediated by external guide sequences
|
US5976874A
(en)
*
|
1996-08-16 |
1999-11-02 |
Yale University |
Phenotypic conversion of drug-resistant bacteria to drug-sensitivity
|
US6884430B1
(en)
|
1997-02-10 |
2005-04-26 |
Aventis Pharma S.A. |
Formulation of stabilized cationic transfection agent(s) /nucleic acid particles
|
US7083786B2
(en)
|
1997-04-03 |
2006-08-01 |
Jensenius Jens Chr |
MASP-2, a complement-fixing enzyme, and uses for it
|
CA2286895C
(en)
|
1997-04-15 |
2010-07-13 |
Commonwealth Scientific And Industrial Research Organisation |
Plant fatty acid epoxygenase genes and uses therefor
|
US7589253B2
(en)
|
1997-04-15 |
2009-09-15 |
Commonwealth Scientific And Industrial Research Organisation |
Fatty acid epoxygenase genes from plants and uses therefor in modifying fatty acid metabolism
|
CZ299473B6
(cs)
|
1997-06-30 |
2008-08-06 |
Rhone-Poulenc Rorer S. A. |
Nukleová kyselina a elektrické pole jako sdruženýprodukt pro prenos nukleové kyseliny do bunek prícne pruhovaného svalstva
|
EP1015590A2
(en)
|
1997-09-16 |
2000-07-05 |
CropDesign N.V. |
Cyclin-dependent kinase inhibitors and uses thereof
|
DE19741375C2
(de)
*
|
1997-09-19 |
1999-10-21 |
Max Planck Gesellschaft |
Transgene Pflanzen, deren oberirdische Teile früher reifen und vollständig absterben
|
CA2304354A1
(en)
|
1997-10-02 |
1999-04-15 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
|
AU1671199A
(en)
|
1997-11-18 |
1999-06-07 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Nucleic acids involved in the responder phenotype and applications thereo
|
US6013447A
(en)
*
|
1997-11-21 |
2000-01-11 |
Innovir Laboratories, Inc. |
Random intracellular method for obtaining optimally active nucleic acid molecules
|
HU230353B1
(hu)
|
1998-03-20 |
2016-02-29 |
Benitec Australia Ltd |
A génexpresszió szabályozása
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
US6248525B1
(en)
|
1998-03-30 |
2001-06-19 |
Yale University |
Method for identifying essential or functional genes
|
CA2331782A1
(en)
|
1998-06-24 |
1999-12-29 |
Musc Foundation For Research Development |
Tissue-specific and target rna-specific ribozymes
|
DE19836098A1
(de)
|
1998-07-31 |
2000-02-03 |
Hoechst Schering Agrevo Gmbh |
Pflanzen, die eine modifizierte Stärke synthetisieren, Verfahren zur Herstellung der Pflanzen, ihre Verwendung sowie die modifizierte Stärke
|
WO2000022130A2
(en)
|
1998-10-15 |
2000-04-20 |
Chiron Corporation |
Metastatic breast and colon cancer regulated genes
|
AU773808B2
(en)
|
1998-11-09 |
2004-06-10 |
Bayer Cropscience Aktiengesellschaft |
Nucleic acid molecules from rice and their use for the production of modified starch
|
EP2336337B1
(en)
|
1998-11-12 |
2015-07-29 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof
|
WO2000036118A2
(en)
|
1998-12-16 |
2000-06-22 |
Chiron Corporation |
HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE)
|
US6271359B1
(en)
|
1999-04-14 |
2001-08-07 |
Musc Foundation For Research Development |
Tissue-specific and pathogen-specific toxic agents and ribozymes
|
AUPQ005299A0
(en)
|
1999-04-29 |
1999-05-27 |
Commonwealth Scientific And Industrial Research Organisation |
Novel genes encoding wheat starch synthases and uses therefor
|
AU778695B2
(en)
|
1999-07-20 |
2004-12-16 |
Ges. Fur Erwerb Und Verwertung Von Schutzrechten-Gvs Mbh |
Novel method for the generation and selection of transgenic linseed/flax plants
|
US6423885B1
(en)
|
1999-08-13 |
2002-07-23 |
Commonwealth Scientific And Industrial Research Organization (Csiro) |
Methods for obtaining modified phenotypes in plant cells
|
CA2797652C
(en)
|
2000-07-21 |
2016-03-08 |
Revance Therapeutics, Inc. |
Multi-component biological transport systems
|
DK1331845T3
(da)
|
2000-11-09 |
2012-04-23 |
Commw Scient Ind Res Org |
Byg med reduceret SSII-aktivitet og stivelsesholdige produkter med et reduceret indhold af amylopectin
|
ITMI20011364A1
(it)
*
|
2001-06-28 |
2002-12-28 |
Metapontum Agrobios S C R L |
Robozima hammerhead specifico per la stearoyl-acp desaturesi di piante oleaginose differenti
|
US7994144B2
(en)
|
2001-07-10 |
2011-08-09 |
Johnson & Johnson Research Pty, Limited |
Process for the preparation of a composition of genetically modified hematopoietic progenitor cells
|
DK1414996T3
(da)
|
2001-07-10 |
2011-03-21 |
Johnson & Johnson Res Pty Ltd |
Fremgangsmåder til genetisk modifikation af hæmatopoetiske progenitorceller og anvendelser af modificerede celler
|
US8022272B2
(en)
|
2001-07-13 |
2011-09-20 |
Sungene Gmbh & Co. Kgaa |
Expression cassettes for transgenic expression of nucleic acids
|
FR2829136B1
(fr)
|
2001-08-29 |
2006-11-17 |
Aventis Pharma Sa |
Derives lipidiques d'aminoglycosides
|
US7456335B2
(en)
|
2001-09-03 |
2008-11-25 |
Basf Plant Science Gmbh |
Nucleic acid sequences and their use in methods for achieving pathogen resistance in plants
|
ATE509120T1
(de)
|
2001-09-18 |
2011-05-15 |
Carnegie Inst Of Washington |
Fusionsproteine zur detektion von analyten
|
WO2003051314A2
(en)
|
2001-12-18 |
2003-06-26 |
Medallion Biomedical, Llc |
Antibiotic compounds
|
US20040005546A1
(en)
|
2002-02-28 |
2004-01-08 |
Oncolytics Biotech Inc. |
Use of ribozymes in the detection of adventitious agents
|
DE10212892A1
(de)
|
2002-03-20 |
2003-10-09 |
Basf Plant Science Gmbh |
Konstrukte und Verfahren zur Regulation der Genexpression
|
EP1900827A3
(en)
|
2002-05-21 |
2008-04-16 |
Bayer HealthCare AG |
Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
|
WO2004003150A2
(en)
|
2002-06-26 |
2004-01-08 |
Yale University |
Modulators and modulation of the interacton between rgm and neogenin
|
ATE405658T1
(de)
|
2002-07-26 |
2008-09-15 |
Basf Plant Science Gmbh |
Neue selektionsverfahren
|
EP2258724A1
(en)
|
2002-11-21 |
2010-12-08 |
Celltech R & D, Inc. |
Modulating immune responses using multimerized anti-CD83 antibodies
|
PT1578973E
(pt)
|
2002-12-19 |
2008-10-16 |
Bayer Cropscience Ag |
Células de plantas e plantas que sintetizam um amido com uma melhor viscosidade final
|
PT1625166E
(pt)
|
2003-05-12 |
2015-08-20 |
Helion Biotech Aps |
Anticorpos para masp-2
|
KR101228720B1
(ko)
|
2003-06-30 |
2013-02-01 |
리마그라인 씨리알레스 인그리디언츠 에스에이 |
변경된 분지 효소작용과 녹말을 가지는 소맥과 이로부터유도된 생성물을 포함하는 녹말
|
EP1522594A3
(en)
|
2003-10-06 |
2005-06-22 |
Bayer HealthCare AG |
Methods and kits for investigating cancer
|
EP1602926A1
(en)
|
2004-06-04 |
2005-12-07 |
University of Geneva |
Novel means and methods for the treatment of hearing loss and phantom hearing
|
US7604947B2
(en)
|
2004-06-09 |
2009-10-20 |
Cornell Research Foundation, Inc. |
Detection and modulation of cancer stem cells
|
US8840893B2
(en)
|
2004-06-10 |
2014-09-23 |
Omeros Corporation |
Methods for treating conditions associated with MASP-2 dependent complement activation
|
EP2465535A1
(en)
|
2004-06-10 |
2012-06-20 |
Omeros Corporation |
Methods for treating conditions associated with MASP-2 dependent complement activation
|
US7919094B2
(en)
|
2004-06-10 |
2011-04-05 |
Omeros Corporation |
Methods for treating conditions associated with MASP-2 dependent complement activation
|
US8237013B2
(en)
|
2004-07-08 |
2012-08-07 |
Dlf-Trifolium A/S |
Means and methods for controlling flowering in plants
|
EP2166103B1
(en)
|
2004-08-02 |
2013-05-22 |
BASF Plant Science GmbH |
Method for isolation of transcription termination sequences
|
CA2579927A1
(en)
|
2004-09-24 |
2006-03-30 |
Basf Plant Science Gmbh |
Plant cells and plants with increased tolerance to environmental stress
|
CA2594155C
(en)
|
2004-12-30 |
2016-08-30 |
Commonwealth Scientific And Industrial Research Organisation |
A process for producing a food or beverage
|
EP1707632A1
(de)
|
2005-04-01 |
2006-10-04 |
Bayer CropScience GmbH |
Phosphorylierte waxy-Kartoffelstärke
|
WO2007039256A2
(de)
|
2005-09-30 |
2007-04-12 |
Abbott Gmbh & Co. Kg |
Bindungsdomänen von proteinen der repulsive guidance molecule (rgm) proteinfamilie und funktionale fragmente davon sowie deren verwendung
|
WO2007054441A2
(de)
|
2005-11-08 |
2007-05-18 |
Basf Plant Science Gmbh |
Verwendung von armadillo-repeat (arm1)-polynukleotiden zum erreichen einer pathogenresistenz in pflanzen
|
EP2380986A1
(en)
|
2006-01-12 |
2011-10-26 |
BASF Plant Science GmbH |
Use of stomatin (STM1) polynucleotides for achieving a pathogen resistance in plants
|
EP2090662A3
(en)
|
2006-04-05 |
2012-10-31 |
Metanomics GmbH |
Process for the production of a fine chemical
|
WO2007134818A2
(en)
|
2006-05-18 |
2007-11-29 |
Univ Muenchen L Maximilians |
Method for diagnosing mitochondrial dysfunction
|
US8383597B2
(en)
|
2006-05-25 |
2013-02-26 |
Cornell Research Foundation, Inc. |
G proteins in tumor growth and angiogenesis
|
CN101600808B
(zh)
|
2006-10-06 |
2014-07-09 |
强生研究有限公司 |
分子开关及其使用方法
|
WO2008087141A2
(en)
|
2007-01-15 |
2008-07-24 |
Basf Plant Science Gmbh |
Use of subtilisin (rnr9) polynucleotides for achieving a pathogen resistance in plants
|
AU2008214568B2
(en)
|
2007-02-16 |
2013-04-18 |
Basf Plant Science Gmbh |
Nucleic acid sequences for regulation of embryo-specific expression in monocotyledonous plants
|
CN101917992A
(zh)
|
2007-03-27 |
2010-12-15 |
奥默罗斯公司 |
用于治疗运动障碍的pde7抑制剂的用途
|
CN101765660B
(zh)
|
2007-05-22 |
2013-10-23 |
巴斯夫植物科学有限公司 |
具有提高的环境胁迫耐受性和/或抗性和提高的生物量生产的植物细胞和植物
|
CL2008002775A1
(es)
|
2007-09-17 |
2008-11-07 |
Amgen Inc |
Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
|
EP2040075A1
(en)
|
2007-09-24 |
2009-03-25 |
Julius-Maximilians-Universität Würzburg |
Compounds and markers for surface-enhanced raman scattering
|
JP2011506483A
(ja)
|
2007-12-14 |
2011-03-03 |
アムジエン・インコーポレーテツド |
抗スクレロスチン抗体を用いた骨折の治療方法
|
EP2240587A2
(en)
|
2007-12-21 |
2010-10-20 |
BASF Plant Science GmbH |
Plants with increased yield (ko nue)
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
EP2100962A1
(en)
|
2008-03-12 |
2009-09-16 |
Biogemma |
Plants having improved resistance to pathogens
|
US10517839B2
(en)
|
2008-06-09 |
2019-12-31 |
Cornell University |
Mast cell inhibition in diseases of the retina and vitreous
|
WO2010026537A1
(en)
|
2008-09-05 |
2010-03-11 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Novel multimodular assembly useful for intracellular delivery
|
EP2184351A1
(en)
|
2008-10-30 |
2010-05-12 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Polynucleotides encoding caryophyllene synthase and uses thereof
|
ES2363358B1
(es)
|
2009-04-03 |
2012-06-21 |
FUNDACIÓ INSTITUT DE RECERCA HOSPITAL UNIVERSITARI VALL D'HEBRON (Titular al |
Agentes terapéuticos para el tratamiento de enfermedades asociadas con una proliferación celular indeseable.
|
US10519458B2
(en)
|
2009-04-22 |
2019-12-31 |
Basf Plant Science Company Gmbh |
Whole seed specific promoter
|
EP2475367A1
(en)
|
2009-09-10 |
2012-07-18 |
Centre National De La Recherche Scientifique |
NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES
|
EP2305285A1
(en)
|
2009-09-29 |
2011-04-06 |
Julius-Maximilians-Universität Würzburg |
Means and methods for treating ischemic conditions
|
KR101788040B1
(ko)
|
2009-10-16 |
2017-10-19 |
오메로스 코포레이션 |
Masp-2 의존성 보체 활성화의 억제에 의한 파종성 혈관내 응고의 치료 방법
|
CA2779073C
(en)
|
2009-10-30 |
2017-10-24 |
Domain Therapeutics |
Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
|
EP2322149A1
(en)
|
2009-11-03 |
2011-05-18 |
Universidad del Pais Vasco |
Methods and compositions for the treatment of ischemia
|
AU2010329955A1
(en)
|
2009-12-08 |
2012-05-24 |
Abbott Gmbh & Co. Kg |
Monoclonal antibodies against the RGM A protein for use in the treatment of retinal nerve fiber layer degeneration
|
EP2338492A1
(en)
|
2009-12-24 |
2011-06-29 |
Universidad del Pais Vasco |
Methods and compositions for the treatment of alzheimer
|
US8476485B2
(en)
|
2010-06-24 |
2013-07-02 |
Academia Sinica |
Non-human animal model for amyotrophic lateral sclerosis (ALS) with loss-of-TDP-43 function
|
US9220715B2
(en)
|
2010-11-08 |
2015-12-29 |
Omeros Corporation |
Treatment of addiction and impulse-control disorders using PDE7 inhibitors
|
CN103547267A
(zh)
|
2010-11-08 |
2014-01-29 |
奥默罗斯公司 |
使用pde7抑制剂治疗成瘾和冲动控制障碍
|
US9644035B2
(en)
|
2011-04-08 |
2017-05-09 |
Omeros Corporation |
Methods for treating conditions associated with MASP-2 dependent complement activation
|
EP2694108B1
(en)
|
2011-04-08 |
2018-06-06 |
University Of Leicester |
Methods for treating conditions associated with masp-2 dependent complement activation
|
US20150017091A1
(en)
|
2011-08-18 |
2015-01-15 |
Cornell University |
Detection and treatment of metastatic disease
|
WO2013039880A1
(en)
|
2011-09-12 |
2013-03-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Biomarkers and therapeutic targets of hepatocellular cancer
|
WO2013090814A2
(en)
|
2011-12-16 |
2013-06-20 |
Board Of Trustees Of Michigan State University |
p-Coumaroyl-CoA:Monolignol Transferase
|
DK2807192T3
(da)
|
2012-01-27 |
2018-07-23 |
Abbvie Deutschland |
Sammensætning og fremgangsmåde til diagnosticering og behandling af sygdomme, der er forbundet med neuritdegeneration
|
EP2825210B1
(en)
|
2012-03-14 |
2019-06-26 |
University of Central Florida Research Foundation, Inc. |
Lim kinasemodulating agents for neurofibromatoses therapy and methods for screening for same
|
EP2666775A1
(en)
|
2012-05-21 |
2013-11-27 |
Domain Therapeutics |
Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors
|
WO2014127835A1
(en)
|
2013-02-22 |
2014-08-28 |
Christian-Albrechts-Universität Zu Kiel |
Plant-derived resistance gene
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
EP3057993B1
(en)
|
2013-10-17 |
2020-08-12 |
Omeros Corporation |
Methods for treating conditions associated with masp-2 dependent complement activation
|
SG11201604871VA
(en)
|
2013-12-18 |
2016-07-28 |
Commw Scient Ind Res Org |
Lipid comprising long chain polyunsaturated fatty acids
|
SG11201610596PA
(en)
|
2014-06-27 |
2017-01-27 |
Commw Scient Ind Res Org |
Lipid comprising docosapentaenoic acid
|
EP3000814A1
(en)
|
2014-09-26 |
2016-03-30 |
Domain Therapeutics |
Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors
|
EA201891570A1
(ru)
|
2016-01-05 |
2018-12-28 |
Юниверсити Оф Лестер |
Способ подавления фиброза у нуждающегося в этом субъекта
|
AU2017240129B2
(en)
|
2016-03-31 |
2020-04-02 |
Omeros Corporation |
Methods for inhibiting angiogenesis in a subject in need thereof
|
JP6995783B2
(ja)
|
2016-05-26 |
2022-02-04 |
ヌンヘムス、ベスローテン、フェンノートシャップ |
種なし果実を実らせる植物
|
CA3033327A1
(en)
|
2016-08-09 |
2018-02-15 |
President And Fellows Of Harvard College |
Programmable cas9-recombinase fusion proteins and uses thereof
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
EP3565891B1
(en)
|
2017-01-09 |
2023-04-12 |
Whitehead Institute for Biomedical Research |
Methods of altering gene expression by perturbing transcription factor multimers that structure regulatory loops
|
EP3592853A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Suppression of pain by gene editing
|
US10883089B2
(en)
|
2017-04-04 |
2021-01-05 |
Wisconsin Alumni Research Foundation |
Feruloyl-CoA:monolignol transferases
|
US10883090B2
(en)
|
2017-04-18 |
2021-01-05 |
Wisconsin Alumni Research Foundation |
P-coumaroyl-CoA:monolignol transferases
|
CN111447940A
(zh)
|
2017-07-17 |
2020-07-24 |
科罗拉多大学评议会 |
预防或治疗由辐射或放射疗法引起的辐射诱发的旁观者效应的组合物和方法
|
US11732274B2
(en)
|
2017-07-28 |
2023-08-22 |
President And Fellows Of Harvard College |
Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
|
TW202402809A
(zh)
|
2017-08-15 |
2024-01-16 |
美商歐米諾斯公司 |
用於治療和/或預防與造血幹細胞移植有關的移植物抗宿主病和/或瀰漫性肺泡出血和/或靜脈閉塞性病的方法
|
WO2019139645A2
(en)
|
2017-08-30 |
2019-07-18 |
President And Fellows Of Harvard College |
High efficiency base editors comprising gam
|
AU2018352592A1
(en)
|
2017-10-16 |
2020-06-04 |
Beam Therapeutics, Inc. |
Uses of adenosine base editors
|
US11584714B2
(en)
|
2018-05-29 |
2023-02-21 |
Omeros Corporation |
MASP-2 inhibitors and methods of use
|
US11291176B2
(en)
|
2018-06-15 |
2022-04-05 |
Nunhems B.V. |
Seedless watermelon plants comprising modifications in an ABC transporter gene
|
WO2020191246A1
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
JP2023504543A
(ja)
|
2019-12-04 |
2023-02-03 |
オメロス コーポレーション |
Masp-2阻害剤および使用方法
|
MX2022014008A
(es)
|
2020-05-08 |
2023-02-09 |
Broad Inst Inc |
Métodos y composiciones para la edición simultánea de ambas cadenas de una secuencia de nucleótidos de doble cadena objetivo.
|
US20240011030A1
(en)
|
2020-08-10 |
2024-01-11 |
Novartis Ag |
Treatments for retinal degenerative diseases
|
WO2024038090A1
(en)
|
2022-08-18 |
2024-02-22 |
Mitodicure Gmbh |
Use of substituted benzoxazole and benzofuran compounds for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance
|
WO2024042160A1
(en)
|
2022-08-26 |
2024-02-29 |
Mitodicure Gmbh |
Use of a therapeutic agent with sodium-hydrogen antiporter 1 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance
|